Beta blockers work by competitively binding to and blocking beta adrenoceptors, a type of receptor, decreasing the heart rate. A drug's mechanism of action describes the specific biochemical interaction of how it produces its pharmacological effect, such as binding to an enzyme or receptor. The molecular targets of drugs are specific to the drug's chemical structure and the action that occurs there. Drugs that don't bind to receptors create their effects by interacting with chemical or physical properties in the body.
Beta blockers work by competitively binding to and blocking beta adrenoceptors, a type of receptor, decreasing the heart rate. A drug's mechanism of action describes the specific biochemical interaction of how it produces its pharmacological effect, such as binding to an enzyme or receptor. The molecular targets of drugs are specific to the drug's chemical structure and the action that occurs there. Drugs that don't bind to receptors create their effects by interacting with chemical or physical properties in the body.
Beta blockers work by competitively binding to and blocking beta adrenoceptors, a type of receptor, decreasing the heart rate. A drug's mechanism of action describes the specific biochemical interaction of how it produces its pharmacological effect, such as binding to an enzyme or receptor. The molecular targets of drugs are specific to the drug's chemical structure and the action that occurs there. Drugs that don't bind to receptors create their effects by interacting with chemical or physical properties in the body.
Beta blockers exert their pharmacological effect, decreased heart rate, by binding to and competitively antagonising a type of receptor called beta adrenoceptors.[1]
In pharmacology, the term mechanism of action (MOA) refers to the specific
biochemical interaction through which a drug substance produces its pharmacological effect.[2] A mechanism of action usually includes mention of the specific molecular targets to which the drug binds, such as an enzyme or receptor.[3] Receptor sites have specific affinities for drugs based on the chemical structure of the drug, as well as the specific action that occurs there. Drugs that do not bind to receptors produce their corresponding therapeutic effect by simply interacting with chemical or physical properties in the body. Common examples of drugs that work in this way are antacids and laxatives.[2] In contrast, a mode of action (MoA) describes functional or anatomical changes, at the cellular level, resulting from the exposure of a living organism to a substance.